Phreesia, Inc. (PHR)
NYSE: PHR · Real-Time Price · USD
16.39
-0.06 (-0.36%)
At close: Jan 16, 2026, 4:00 PM EST
16.35
-0.04 (-0.24%)
After-hours: Jan 16, 2026, 7:22 PM EST
Phreesia Market Cap
Phreesia has a market cap or net worth of $988.1 million as of January 16, 2026. Its market cap has decreased by -32.43% in one year.
Market Cap
988.10M
Enterprise Value
892.16M
1-Year Change
-32.43%
Ranking
Category
Stock Price
$16.39
Market Cap Chart
Since July 18, 2019, Phreesia's market cap has increased from $882.45M to $988.10M, an increase of 11.97%. That is a compound annual growth rate of 1.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 988.10M | -3.13% |
| Dec 31, 2025 | 1.02B | -30.25% |
| Dec 31, 2024 | 1.46B | 13.55% |
| Dec 29, 2023 | 1.29B | -24.54% |
| Dec 30, 2022 | 1.71B | -20.04% |
| Dec 31, 2021 | 2.13B | -10.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 923.07B |
| Johnson & Johnson | 527.49B |
| AbbVie | 384.83B |
| UnitedHealth Group | 305.89B |
| AstraZeneca | 291.28B |
| Novartis AG | 278.73B |
| Merck & Co. | 274.78B |
| Novo Nordisk | 262.20B |